Personalis (PSNL) Cash from Investing Activities (2018 - 2026)
Personalis (PSNL) recorded quarterly Cash from Investing Activities of -$46.0 million in Q1 2026, down 219.99% quarter-over-quarter from -$14.4 million in Q4 2025, and down 104.12% on a YoY basis from $1.1 billion in Q1 2025.
Personalis (PSNL) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Personalis' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$46.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 104.12% year-over-year to -$46.0 million; the TTM figure through Mar 2026 stood at -$46.0 million (up 27.97% YoY), while the FY2025 annual figure was -$22.6 million, up 35.65% from the prior year.
- Cash from Investing Activities was -$46.0 million for Q1 2026 at Personalis, down from -$14.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $23.0 million in Q2 2022 to a low of -$46.0 million in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$2.2 million across 5 years, with a median of -$3.2 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities soared 536.35% in 2023, then tumbled 457.75% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at $21.9 million in 2022, then slumped by 153.26% to -$11.6 million in 2023, then plunged by 124.98% to -$26.2 million in 2024, then surged by 45.08% to -$14.4 million in 2025, then slumped by 219.99% to -$46.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$46.0 million (Q1 2026), -$14.4 million (Q4 2025), and $18.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Personalis | 1.01 Bn | 780.57 Mn | 281,000.00 | -46.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.01 Mn |
| Mar 31, 2026 | -46.01 Mn |
| Dec 31, 2025 | -14.38 Mn |
| Dec 31, 2025 | -14.38 Mn |
| Sep 30, 2025 | 18.72 Mn |
| Sep 30, 2025 | 18.72 Mn |
| Jun 30, 2025 | -4.37 Mn |
| Jun 30, 2025 | -4.37 Mn |
| Mar 31, 2025 | -22.54 Mn |
| Mar 31, 2025 | -22.54 Mn |
| Dec 31, 2024 | -26.18 Mn |
| Dec 31, 2024 | -26.18 Mn |
| Sep 30, 2024 | -28.18 Mn |
| Sep 30, 2024 | -28.18 Mn |
| Jun 30, 2024 | 12.99 Mn |
| Jun 30, 2024 | 12.99 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | -11.64 Mn |
| Dec 31, 2023 | -11.64 Mn |